Durect Corporation
Overview
Durect Corporation is a biopharmaceutical company engaged in the research and development of pharmaceutical products based on its proprietary drug delivery technology. The company's product pipeline is focused on the treatment of chronic pain and other medical needs.
Therapeutic areas
Active pharmaceutical ingredients supplied
Substances Durect Corporation is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
Durect Corporation holds 4 active (4 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- DUR-928-AActive2022-03-14
- PLACEBO FOR DUR-928 TOPICAL SOLUTIONActive2018-07-17
- DUR-928 TOPICAL SOLUTIONActive2018-07-16
- DUR-928Active2016-12-22
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Durect Corporation in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Durect Corporation? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.